TRANSFORMING GROWTH FACTOR β1 AND SOLUBLE FAS SERUM LEVELS IN HEPATOCELLULAR CARCINOMA
- 30 June 2000
- Vol. 12 (6) , 811-814
- https://doi.org/10.1006/cyto.1999.0650
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.The Journal of Experimental Medicine, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Frequency of raised α-fetoprotein level among Chinese patients with hepatocellular carcinoma related to hepatitis B and CBritish Journal of Cancer, 1994
- Protection from Fas-Mediated Apoptosis by a Soluble Form of the Fas MoleculeScience, 1994
- Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosisJournal of Hepatology, 1994
- Transforming Growth Factors β1 and α in Chronic Liver DiseaseNew England Journal of Medicine, 1991
- Growth factors in development, transformation, and tumorigenesisCell, 1991
- Expression of Transforming Growth Factor‐β1 mRNA in Human Hepatocellular CarcinomaJapanese Journal of Cancer Research, 1990
- TGF‐β in Liver Development, Regeneration, and CarcinogenesisaAnnals of the New York Academy of Sciences, 1990